https://t.co/7mEzphrR6t Reports: Mateon Therapeutics (MATN) expands its management team to accelerate the commercialization and development of OT-101 for COVID-19 

$MATN

#Investing #Stocks #PennyStocks #OTCmarkets #SmallCapStocks #HighRiskHighReturns

https://t.co/m9CPgxr9YE